Boston Medical Sciences
$6.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Boston Medical Sciences is currently valued at $31.0M as of October 8, 2024. The company has raised a total of $9.2M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.38x, Boston Medical Sciences has achieved a valuation that is 3.38 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Boston Medical Sciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Boston Medical Sciences Worth in 2025?
As of 2025, Boston Medical Sciences is valued at $31.0M, based on the company's Early Stage VC funding round in October 8, 2024. This valuation positions Boston Medical Sciences as one of the leading private companies in the sector.
Boston Medical Sciences Valuation History
Boston Medical Sciences's funding history demonstrates steady growth and investor confidence.
How Boston Medical Sciences Valuation is Determined
Private company valuations like Boston Medical Sciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Boston Medical Sciences Valuation FAQs
Is Boston Medical Sciences profitable?
Boston Medical Sciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Boston Medical Sciences's valuation compare to competitors?
Boston Medical Sciences is valued at $31.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Boston Medical Sciences IPO?
Boston Medical Sciences has not announced plans for an initial public offering. Until an IPO, investors can access Boston Medical Sciences shares through secondary market platforms.